Safety of stapler vs. non-stapler closure of the pancreatic remnant after distal pancreatectomy: a multicenter randomized controlled trial
Phase 3
- Conditions
- Benign and malignant pancreatic neoplasms indicated for distal pancreatectomy
- Registration Number
- JPRN-UMIN000004838
- Lead Sponsor
- ational Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
Not provided
Exclusion Criteria
1)Chemotherapy, immunotherapy, or radiotherapy before operation 2)Possibility of total pancreaterctomy, or combined celiac artery resection 3)Severe comorbid illness needing postoperative care under ICU 4)Severe psychiatric or neurologic diseases 5)Pregnancy 6)Lack fo compliance
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical pancreatic fistul rate
- Secondary Outcome Measures
Name Time Method Operative time, bleeding, chemical pancreatic fistula rate, duration of drain placement, complications, duration of hospital stay, severe complication rate